HER2-Positive Breast Cancer Survivors
1 clinical trials · Condition
◉ Watch HER2-Positive Breast Cancer Survivors
| Record | Firm | Date |
|---|---|---|
| Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors (NCT02615054) | Memorial Sloan Kettering Cancer Center | 2015-11-18 |
Track HER2-Positive Breast Cancer Survivors automatically
Every clearance here is in the API, with alerts when new ones post.